About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Biomedical Research Group in Gynaecology is a multidisciplinary team made up of clinical specialists in gynaecology and pathology and basic and translational researchers. Our research is clearly translational. Although we take into account the obvious importance of understanding the mechanism at the cellular and molecular level and try to incorporate it into our research, our research is always focused on having a direct applicability to patients and their clinical benefit. On our way to transferring scientific results to clinical practice, we promote innovation and entrepreneurship.
Our group comprises four main research groups, which are closely connected: The clinical research group devoted mainly to clinical projects in all gynaecological cancers; and three translational research groups dedicated to ovarian cancer; endometrial cancer and endometriosis; diseases of the lower female genital tract.
PMID: 35303394 Journal: BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY Year: 2022 Reference: BJOG. 2022 Mar 18. doi: 10.1111/1471-0528.17151. Impact factor: 6.531 Publication type: Paper in international publication Authors: Carreras, Elena, Armengol, Mireia, Bonacina, Erika, Mendoza, Manel, Farras, Alba, Garcia-Manau, Pablo, Serrano, Berta, Hurtado, Ivan, Ferrer-Oliveras, Raquel, Illan, Lidia et al. DOI: 10.1111/1471-0528.17151
PMID: 35292711 Journal: Scientific Reports Year: 2022 Reference: Sci Rep. 2022 Mar 15;12(1):4445. doi: 10.1038/s41598-022-08461-0. Impact factor: 4.38 Publication type: Paper in international publication Authors: Gil-Moreno, Antonio, Sabido, Eduard, Santamaria, Anna, Perez-Benavente, Assumpcio, Sanchez-Iglesias, Jose Luis, Castellvi, Josep, Bradbury, Melissa, Borras, Eva, Mendez, Olga et al. DOI: 10.1038/s41598-022-08461-0
PMID: 34217852 Journal: Journal of Minimally Invasive Gynecology Year: 2022 Reference: J Minim Invasive Gynecol. 2022 Jan;29(1):103-113. doi: 10.1016/j.jmig.2021.06.027. Epub 2021 Jul 1. Impact factor: 4.137 Publication type: Paper in international publication Authors: Diaz-Feijoo, Berta, Acosta, Ursula, Torne, Aureli, Gil-Ibanez, Blanca, Hernandez, Alicia, Domingo, Santiago, Gil-Moreno, Antonio et al. DOI: 10.1016/j.jmig.2021.06.027
The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.
On World Cancer Research Day, we highlight research aimed at improving treatments for both pediatric and adult cancers through innovative techniques.
From 6th to 7th March, more than 60 European researchers have shared the advances in translational research in endometrial cancer
